Toggle navigation
PDFSEARCH.IO
Document Search Engine - browse more than 18 million documents
Sign up
Sign in
Back to Results
First Page
Meta Content
View Document Preview and Link
7.10 FLUTICASONE+VILANTEROL, dry powder inhaler, fluticasone furoate 100 microgram/actuation + vilanterol (as trifenatate) 25 microgram/actuation, Breo® Ellipta®, GlaxoSmithKline Australia Pty Ltd.
Add to Reading List
Document Date: 2015-04-22 23:39:46
Open Document
File Size: 50,54 KB
Share Result on Facebook
Company
GlaxoSmithKline Australia Pty Ltd /
The PBAC /
/
Country
Australia /
/
IndustryTerm
pharmaceutical /
treatment of chronic obstructive pulmonary disease /
/
MedicalCondition
chronic obstructive pulmonary disease /
pneumonia /
COPD /
asthma /
/
Position
Minister /
nurse /
/
Product
fluticasone propionate /
beta-2 /
/
SocialTag
GlaxoSmithKline
Glucocorticoids
Organofluorides
Chronic lower respiratory diseases
Chronic obstructive pulmonary disease
Fluticasone/salmeterol
Formoterol
Fluticasone propionate
Salmeterol
Pulmonology
7.10 FLUTICASONE+VILANTEROL, dry powder inhaler, fluticasone furoate 100 microgram/actuation + vilanterol (as trifenatate) 25 microgram/actuation, Breo® Ellipta®, GlaxoSmithKline Australia Pty Ltd.